Comet Therapeutics

Developer of enzyme substitution therapy for neurological diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups4 employees language comettherapeutics.com

Innovation

5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 89 times.

YearFilings
20203
20213
20224
20233
20242
20251

Investor mix

4 investors on record; lead investors include Canaan, Sofinnova Partners, Inkef.

Investor typeCountShare
Venture capital4100%
Coming soon